U.S. Metals and Mining Stock News

Some investors rely on dividends for growing their wealth, and if you're one of those dividend sleuths, you might be...

Some investors rely on dividends for growing their wealth, and if you're one of those dividend sleuths, you might be...

Wondering if Arcellx at around US$114 per share still offers value, or if the easy money has already been made. The stock has YTD returns of 81.0% and a 1 year return of 68.7%, although the past week has been flat at around a 0.1% decline and the 30 day move sits at 0.8%. Recent coverage has focused on Arcellx as a higher growth biotech name, which helps explain why the share price has been so strong over the past year. That kind of attention often shifts how investors think about both the...

Arlo Technologies recently reported a past quarter in which revenue grew 16.2% year on year, beating analyst forecasts by 4.2% and delivering earnings per share above expectations for both the reported period and its next-quarter guidance. The company also moved from negative to positive full-year earnings per share over the last five years, highlighting a key profitability inflection that builds on its 8.2% annualized revenue growth in the same period. Next, we will examine how Arlo’s...

Intellicheck, Inc. ( NASDAQ:IDN ) recently posted some strong earnings, and the market responded positively. We did...

Over the last 7 days, the United States market has experienced a 1.6% decline, though it remains up by 15% over the past year with earnings projected to grow by 16% annually. In this context, identifying small-cap stocks that are potentially undervalued and exhibit insider action can offer intriguing opportunities for investors seeking to navigate these dynamic market conditions.

Over the last 7 days, the United States market has experienced a 1.6% drop, yet it has shown resilience with a 15% increase over the past year and expectations for earnings to grow by 16% annually in the coming years. In this context of fluctuating short-term performance but promising long-term growth prospects, identifying high growth tech stocks that can capitalize on these trends becomes essential for investors seeking potential opportunities.

Wondering whether PROG Holdings at around US$29.02 actually offers value, or if the recent share price leaves limited upside? This breakdown helps you frame that question with numbers, not guesswork. The stock is up 3.8% over the last week, sits at a 21.7% decline over 30 days, and is around 1.2% lower year to date. The 1 year and 3 year returns are 7.7% and 33.6%, and the 5 year return is a 33.8% decline. Recent headlines around PROG Holdings have focused on its position within the broader...

Over the last 7 days, the United States market has experienced a 1.6% decline, yet it has shown resilience with a 15% rise over the past year and an anticipated earnings growth of 16% annually in the coming years. In this environment, identifying stocks that may be underestimated requires looking beyond short-term fluctuations to find companies with strong fundamentals and potential for long-term value appreciation.

Over the last 7 days, the market has dropped 1.6%, but it remains up by 15% over the past year, with earnings expected to grow by 16% annually. In such a climate, identifying stocks with solid financial health can be crucial for investors looking for growth opportunities. Penny stocks—often associated with smaller or newer companies—still hold potential when they demonstrate financial strength and long-term promise.

One thing we could say about the covering analyst on Perma-Fix Environmental Services, Inc. ( NASDAQ:PESI ) - they...

Even when a business is losing money, it's possible for shareholders to make money if they buy a good business at the...

Readers hoping to buy Zimmer Biomet Holdings, Inc. ( NYSE:ZBH ) for its dividend will need to make their move shortly...

Even if it's not a huge purchase, we think it was good to see that Edward Stenger, the Independent Director of Team...

LENZ Therapeutics, Inc. ( NASDAQ:LENZ ) just released its latest yearly report and things are not looking great. It was...

The Morning Bull - US Market Morning Update Friday, Mar, 27 2026 US stock futures are mixed this morning, with S&P 500 contracts hovering near flat as investors weigh higher borrowing costs against hotter inflation and geopolitical risk. The US 10 year Treasury yield is holding around 4.41%, which keeps pressure on everything from credit cards to business loans, while the average 30 year mortgage rate sits at 6.38%, keeping home buying more expensive. At the same time, Middle East tensions...

SIGA Technologies (NasdaqGM:SIGA) has declared a special cash dividend for its shareholders. The announcement provides a direct cash return in addition to any regular dividend policy the company may have. The timing of the dividend decision highlights management's current view of the company’s cash position and capital needs. SIGA Technologies focuses on health security solutions, including products designed for infectious disease and biodefense settings. A special cash dividend draws...

We feel now is a pretty good time to analyse Prothena Corporation plc's ( NASDAQ:PRTA ) business as it appears the...

LCI Industries stock in focus after recent performance shifts LCI Industries (LCII) has drawn investor attention following mixed recent share performance, with a small gain over the past week contrasting with a loss over the past month and flat movement over the past 3 months. See our latest analysis for LCI Industries. Looking beyond the recent swings, the 1 year total shareholder return of 41.45% and 3 year total shareholder return of 31.07% point to momentum that contrasts with the weaker...

We wouldn't blame Best Buy Co., Inc. ( NYSE:BBY ) shareholders if they were a little worried about the fact that Corie...

Celcuity (NasdaqCM:CELC) received FDA Priority Review for its New Drug Application for gedatolisib in advanced breast cancer. The Priority Review follows strong Phase 3 efficacy results from the VIKTORIA-1 trial in HR-positive, HER2-negative breast cancer. An additional Phase 3 readout for the PIK3CA mutant cohort is upcoming and could further influence treatment standards for this patient group. Celcuity focuses on targeted therapies for cancer, with gedatolisib as a key asset in its...

NextDecade Corporation ( NASDAQ:NEXT ) shareholders (or potential shareholders) will be happy to see that insider...

AM Best affirmed the credit ratings and outlook for OneMain Holdings’ insurance subsidiaries, reinforcing its view of their financial strength. The decision reflects AM Best’s current assessment of the subsidiaries’ balance sheet quality, risk management and operating performance. For investors watching OneMain Holdings (NYSE:OMF), this rating affirmation comes alongside a mixed share price record. The stock closed at $53.05, with a 4.0% gain over the past week offsetting a 3.9% decline...

If you are wondering whether Lamb Weston Holdings' current share price reflects its underlying value, this article walks through the key signals you can use to judge that for yourself. The stock most recently closed at US$40.83, with returns of 0.5% over 7 days, a 14.9% decline over 30 days, a 3.5% decline year to date and a 22.1% decline over 1 year, alongside a 57.8% decline over 3 years and a 42.9% decline over 5 years. These moves have kept Lamb Weston on the radar for investors looking...